Sunday 22 April 2018

Roche arthritis drug 'beats top-selling rival'

Roche said on Wednesday that a trial had shown its rheumatoid arthritis drug RoActemra was more effective in reducing swelling and tenderness in joints than Abbott Laboratories' top-selling Humira when given as a single treatment. Humira i


Wider use of Roche arthritis drug approved

Roche has won European backing for broader use of its arthritis drug RoActemra to treat children with a rare and severe form of the disease, the Swiss drugmaker said. The medicine, known as Actemra outside of Europe, is already used to tre


Roche arthritis drug effective as sole therapy

Roche's rheumatoid arthritis drug RoActemra helps treat patients with the painful and debilitating disease regardless of whether it is given on its own or in combination with another drug, a late-stage study showed. The news could boost Ro


New Roche arthritis drug wins approval

Roche Holding AG has won final approval to sell its new rheumatoid arthritis drug, RoActemra, in Europe, the Swiss drugmaker said on Wednesday. The green light from the European Commission had been expected following a positive opinion fro

 1 2 3 4 5 >  Last ›

calendarCalendar of Events